Ulcerative Colitis Diagnosis and Management

Clinical Presentation and Diagnosis

The European Crohn's and Colitis Organisation emphasizes that patients with endoscopically documented distal colitis who previously responded to combined oral and rectal therapy have a predictable relapse pattern when medications are stopped 1
Left lower quadrant tenderness suggests distal colitis or proctosigmoiditis, the most common initial presentation of UC 2
Previous response to oral and rectal medications strongly suggests UC, as this treatment pattern (5-aminosalicylates) is first-line therapy for distal UC 1, 2

Discontinuation of oral and rectal 5-ASA therapy after symptom improvement is a common cause of disease flare 1, 2
Approximately 50% of UC patients may relapse annually, particularly after stopping maintenance therapy, although this specific statistic is not directly cited, the concept of relapse after medication discontinuation is supported by 1, 2

Flexible sigmoidoscopy with biopsies is the essential next step to confirm the diagnosis and assess disease severity, as recommended by guidelines from the European Crohn's and Colitis Organisation 3, 2
Sigmoidoscopy is sufficient for distal colitis and avoids the risks of full colonoscopy in active disease 3, 2
Biopsies must be obtained to confirm chronic inflammation and exclude other causes 3, 2
Do not perform full colonoscopy in acute colitis due to perforation risk; flexible sigmoidoscopy is adequate 3, 2
Always exclude C. difficile infection before attributing symptoms to UC flare, as this can mimic or coexist with IBD 1
Do not delay reinitiation of therapy once infectious causes are excluded, as mucosal healing predicts better long-term outcomes 2

The triad of abdominal pain, bloody diarrhea, and weight loss is characteristic of inflammatory bowel disease, particularly UC in this age group 4, 5
Weight loss correlates with more severe disease activity 6
A strong family history of similar symptoms suggests a genetic inflammatory bowel disease rather than familial adenomatous polyposis (FAP) 4, 5
UC has significant genetic predisposition, and family history is a key risk factor 4

Perform colonoscopy with biopsies to confirm diagnosis, which is the gold standard for UC diagnosis 4, 5
Obtain stool cultures to exclude infectious causes including C. difficile 4, 7
Complete blood count, ESR, and CRP can assess for anemia, inflammation, and disease activity 4, 7, 8
Serum albumin and fecal calprotectin levels can indicate severe disease and active inflammation 6, 7

Familial Adenomatous Polyposis (FAP) is unlikely due to the presentation with bloody diarrhea, abdominal pain, and weight loss, rather than polyp-related complications 4, 5
Diverticulosis is highly unlikely in a 25-year-old patient with a strong family history of similar symptoms 4, 5
Crohn's disease should be considered in the differential, though the family history pattern and bloody diarrhea favor UC 4, 5, 8

Do not delay endoscopic evaluation, as colonoscopy with biopsy is essential for definitive diagnosis 4, 5
Always exclude infectious causes before diagnosing IBD, particularly C. difficile 7
In young patients with bloody diarrhea and family history, IBD should be the primary consideration over other causes 4, 7